Recently Published Articles

2025   2024   2023   2022   2021   2020   2019   2018   2017   2016

Management of IgE-Mediated Food Allergies in K-12 Schools and Early Childcare Centers. Hoyt AEW, Pappalardo AA, Laubach S, Bingemann TA. Immunology and allergy clinics of North America. 2025 August 45 (3):457-471.

New Insights into the Pathogenesis of Psoriatic Arthritis. Garcia-Hernandez ML, Ritchlin CT, Guy DR, Wechalekar M. Rheumatic diseases clinics of North America. 2025 August 51 (3):397-415.

Guselkumab Efficacy in Biologic-Naïve Participants with Psoriatic Arthritis and Severe Disease Activity: Post Hoc Analysis of a Phase 3 Study. Ritchlin CT, Lubrano E, Chimenti MS, Leibowitz E, Sharaf M, Rampakakis E, Nantel F, Lavie F, Deodhar A. Rheumatology and therapy. 2025 July 21.

Corrigendum to Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study Ann Rheum Dis. 2023;82:1404-1414. Ritchlin CT, Coates LC, McInnes IB, Mease PJ, Merola JF, Tanaka Y, Asahina A, Gossec L, Gottlieb AB, Warren RB, Ink B, Bajracharya R, Shende V, Coarse J, Landewé RBM. Ann Rheum Dis. 2025 Jun 18:S0003-4967(25)01022-2. Epub ahead of print. Erratum for: Ann Rheum Dis. 2023 Nov;82(11):1404-1414.

Correction: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies. Mease PJ, Merola JF, Tanaka Y, Gossec L, McInnes IB, Ritchlin CT, Landewé RBM, Asahina A, Ink B, Heinrichs A, Bajracharya R, Shende V, Coarse J, Coates LC. Rheumatology and therapy. Rheumatol Ther. 2025 Jun;12(3):597-599. Erratum for: Rheumatol Ther. 2024 Oct;11(5):1363-1382.

Analysis of human factor H-related gene and protein expressed in rheumatoid arthritis synovium identifies a novel mechanism promoting dysregulated complement pathway activation. Banda NK, Moreland LW, Deane KD, Simberg D, Scheinman RI, Frank RM, Seifert JA, Lau R, Pitzalis C, Lewis MJ, Holers VM, Scientific report. 2025 June 415 (1):19633.

TNF drives aberrant BMP signaling to induce endothelial and mesenchymal dysregulation in pulmonary hypertension. Garcia-Hernandez ML, Rangel-Moreno J, Xu Q, Jeong YJ, Bhattacharya S, Misra R, Duemmel S, Yuan K, Korman BD. JCI insight. 2025 June 26.

Where to challenge?: That is the question. Bartnikas LM, Bingemann TA. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2025 June 134 (6):626-627.

B Cell-Directed Therapy in Autoimmunity. Abeles I, Palma C, Meednu N, Payne AS, Looney RJ, Anolik JH. Annual review of immunology. 2024 June 42 (1):103-126.

Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis. Horisberger A, Griffith A, Keegan J, Arazi A, Pulford J, Murzin E, Howard K, Hancock B, Fava A, Sasaki T, Ghosh T, Inamo J, Beuschel R, Cao Y, Preisinger K, Gutierrez-Arcelus M, Eisenhaure TM, Guthridge J, Hoover PJ, Dall'Era M, Wofsy D, Kamen DL, Kalunian KC, Furie R, Belmont M, Izmirly P, Clancy R, Hildeman D, Woodle ES, Apruzzese W, McMahon MA, Grossman J, Barnas JL, Payan-Schober F, Ishimori M, Weisman M, Kretzler M, Berthier CC, Hodgin JB, Demeke DS, Putterman C, Brenner MB, Anolik JH, Raychaudhuri S, Hacohen N, James JA, Davidson A, Petri MA, Buyon JP, Diamond B, Zhang F, Lederer JA, Rao DA. The Journal of clinical investigation. 2025 June 19.

Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab. Brandt-Jurgens, J; Rudwaleit, M; Behrens, F; Ritchlin, C; Peterlik, D; Quebe-Fehling, E; Deodhar, A. Ther Adv Musculoskelet Dis. 2025 Jun 6:17:1759720X251340255.

Where to Challenge?: That is the Question. Bartnikas, LM; Bingemann, TA. Editorial Ann Allergy Asthma Immunol. 2025 Jun;134(6):626-627.

Summary of Research: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies. Mease PJ, Merola JF, Tanaka Y, Gossec L, McInnes IB, Ritchlin CT, Landewé RBM, Asahina A, Ink B, Heinrichs A, Bajracharya R, Shende V, Coarse J, Coates LC. Rheumatology and therapy. 2025 May 10.

Automated Joint Space Detection Improves Bone Segmentation Accuracy. Kenney HM, Lichau D, Blanc R, Schnur L, Bell RD, Ritchlin CT, Schwarz EM, Awad HA, Wood RW. bioRxiv : the preprint server for biology. 2025 May 6.

Partnership with minority ethnic communities is crucial to tackling health inequalities in rheumatology: lessons from Rochester, New York, US. Kanta Kumar, Edith Williams, Allen Anandarajah, Lisa Roberts, Shirish Dubey, Arumugam Moorthy, Ade Adeba. Clinical Rheumatology. Clin Rheumatol. 2025 May;44(5):1867-1869. Epub 2025 Mar 25.

10 ways to improve your management of food allergy. Anagnostou A, Lieberman J, Bingemann T, Buckey T, Cianferoni A, Cosper A, Kim E, Love M, Mallapaty A, Moore L, Wasserman R, Nowak-Wegrzyn A, Somani S, Yu J, Greenhawt M. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2025 May 134 (5):616-618.

Granzyme K activates the entire complement cascade. Donado CA, Theisen E, Zhang F, Nathan A, Fairfield ML, Rupani KV, Jones D, Johannes KP, Raychaudhuri S, Dwyer DF, Jonsson AH, Brenner MB. Nature. 2025 May 641 (8061):211-221.

A Phenotypically Distinct Human Th2 Cell Subpopulation Is Associated With Development of Allergic Disorders in Infancy. Pizzarello CR, Jackson CM, Herman K, Seppo AE, Rebhahn J, Scherzi T, Berin MC, Looney RJ, Mosmann TR, Järvinen KM. Allergy. 2025 April 80 (4):949-964.

SARS-CoV-2 N protein and anti-spike serologies: insights into COVID-19 disease severity and mortality-a secondary analysis of the ACTIV-1 trial. Mena Lora AJ, Enders K, Wu H, Parra-Rodriguez L, Palma C, Saliba K, Laverdurre S, Smith PB, Anstrom KJ, Bozzette SA, Powderly WG. Ther Adv Infect Dis. 2025 Apr 22;12:20499361251333617.

Insect Allergy: Barriers in Training and Practice-A Work Group Report of the AAAAI Anaphylaxis Committee. Adams K, Greenhawt M, Bingemann T, Tracy J, Brooks J, Otto H, Steigelman D, Hsieh Y, Anagnostou A, Carlson J, Demain J, Harish A, Hein N, Nanda A, Hajirawala M, Waserman S, Golden DBK. The journal of allergy and clinical immunology. In practice. 2025 March 13 (3):501-510.

Evaluation of Vaccinia Virus Infection in Mice Using Two-Reporter Recombinant Virus. Nogales A, Chiem K, Lorenzo MM, Rangel-Moreno J, de la Luz Garcia-Hernandez M, Park JG, Blasco R, Martinez-Sobrido L. Methods in molecular biology. 2025 2860 :157-174.

Prevention of acute systemic reaction during LDL apheresis post COVID-19 by icatibant pretreatment. Davidson LR, Baecher N, Cheung B, McIntosh S, Bingemann TA, Block RC. Journal of clinical lipidology. 2025 March 21.

Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis. Inamo J, Keegan J, Griffith A, Ghosh T, Horisberger A, Howard K, Pulford JF, Murzin E, Hancock B, Dominguez ST, Gurra MG, Gurajala S, Jonsson AH, Seifert JA, Feser ML, Norris JM, Cao Y, Apruzzese W, Bridges SL, Bykerk VP, Goodman S, Donlin LT, Firestein GS, Bathon JM, Hughes LB, Filer A, Pitzalis C, Anolik JH, Moreland L, Hacohen N, Guthridge JM, James JA, Cuda CM, Perlman H, Brenner MB, Raychaudhuri S, Sparks JA, Holers VM, Deane KD, Lederer J, Rao DA, Zhang F. The Journal of clinical investigation. 2025 March 17135 (6).

Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network. Carlucci PM, Preisinger K, Deonaraine KK, Zaminski D, Dall'Era M, Gold HT, Kalunian K, Fava A, Belmont HM, Wu M, Putterman C, Anolik J, Barnas JL, Furie R, Diamond B, Davidson A, Wofsy D, Kamen D, James JA, Guthridge JM, Apruzzese W, Rao D, Weisman MH, Izmirly PM, Buyon J, Petri M. Rheumatology. 2025 March 164 (3):1193-1200.

Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial. Haidar G, Thomas S, Loubet P, Baker RI, Benfield T, Boonyaratanakornkit J, Kiertiburanakul S, Kim AHJ, Longbrake EE, Molina JM, Paredes R, Tucker D, Uriel A, Weinmann-Menke J, Aksyuk AA, Clegg LE, Currie A, Yang H, Flyrin K, Gibbs M, Shroff M, Perez JL, Chang LJ, Cohen TS. The Lancet. Infectious diseases. 2025 February 24.

Tofacitinib Efficacy/Safety in Patients with Ankylosing Spondylitis by Baseline Body Mass Index: A Post Hoc Analysis of Phase 2/3 Trials. Norton H, Sliwinska-Stanczyk P, Hala T, El-Zorkany B, Stockert L, Mundayat R, Wang L, Ritchlin CT. Rheumatology and therapy. 2025 February 12 (1):67-84.

Training to Increase Minority Enrollment in Lupus Clinical Trials with Community Engagement:  Enhancing Lupus Clinical Trial Recruitment Through provider and Community Health Worker Engagement. Saira Z Sheikh, Tessa Englund, Andrew Simkus, Nicole Wanty, Annie McNeill, Kristen Holtz, Tenesha Hood, Starla Blanks, Maria Allen, Katherine Holben, Allen Anandarajah. Arthritis Care Res. 2025 Feb;77(2):201-208.

Interferon activation in bone marrow long-lived plasma cells in systemic lupus erythematosus. Alzamareh DF, Meednu N, Nandedkar-Kulkarni N, Krenitsky D, Barnard J, Yasaka K, Durrett W, Thakar J, Rangel-Moreno J, Anolik JH, Barnas JL. Front Immunol. 2025 Jan 10;15:1499551.

CD209d/e promotes inflammation and lung injury during influenza virus infection. Gopal R, Marinelli MA, Rago F, Richwalls LJ, Constantinesco NJ, Debnath D, Kupul S, Garcia-Hernandez ML, Rangel-Moreno J, Kolls JK, Alcorn JF. ImmunoHorizons. 2025 January 239 (1).